Related Experiment Video
Updated: Apr 17, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
AT1 Angiotensin receptors-vascular and renal epithelial pathways for blood pressure regulation
Daian Chen1, Thomas M Coffman2
1Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, NC 27710, USA.
Insights
Angiotensin type 1 (AT1) receptors in the kidney play a crucial role in blood pressure regulation and hypertension. Blocking these receptors can effectively lower blood pressure, highlighting their therapeutic potential.
Area of Science:
- Cardiovascular Physiology
- Renal Pathophysiology
- Pharmacology
Background:
- Angiotensin type 1 (AT1) receptors mediate angiotensin II's effects, crucial for blood pressure regulation.
- AT1 receptor blockade effectively treats hypertension, underscoring their role in the condition.
- While AT1 receptors are widespread, their direct renal actions are increasingly recognized for blood pressure control.
Purpose of the Study:
- To review evidence implicating direct renal actions of AT1 receptors in blood pressure regulation and hypertension.
- To examine the kidney's epithelium and vasculature as key cellular targets for AT1 receptor activation.
- To explore novel regulatory mechanisms involving peptides associated with the AT1 receptor C-terminus.
Main Methods:
- Review of recent scientific literature and studies.
- Analysis of evidence on AT1 receptor function in renal cells.
- Examination of peptide interactions with the AT1 receptor.
Main Results:
- Direct activation of renal AT1 receptors significantly impacts blood pressure.
- Renal epithelium and vasculature are identified as critical sites for AT1 receptor action.
- Novel regulatory peptides associated with the AT1 receptor C-terminus have been identified.
Conclusions:
- The kidney's AT1 receptors are pivotal in blood pressure homeostasis and hypertension pathogenesis.
- Targeting renal AT1 receptors offers a promising strategy for managing hypertension.
- Further research into AT1 receptor regulatory peptides may reveal new therapeutic avenues.
Abstract:
Angiotensin type 1 (AT1) receptors are key effector elements of the renin-angiotensin system, mediating virtually all of the classical physiological actions of angiotensin II. Pharmacological blockade of the AT1 receptor effectively lowers blood pressure in a substantial proportion of patients with hypertension, indicating the pivotal role of these receptors in human hypertension. AT1 receptors are expressed in many different organ systems where they have myriad cellular actions. However, several lines of evidence have suggested that direct actions of AT1 receptors in kidney have a major role in regulation of blood pressure and in the pathogenesis of hypertension. Here we review recent studies suggesting that renal epithelium and vasculature may be key cellular targets, where AT1 receptor activation has powerful physiological impact. We will also examine novel regulatory mechanisms by peptides associated with the C-terminus of the AT1 receptor.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Hormonal Regulation
Hypertension II: Pathophysiology
Antihypertensive Drugs: Action of β1 Blockers

